Skip to main content
Log in

Characteristics ofN-formyl-methionyl-leucyl-phenylalanine as an inducer of lysosomal enzyme release from human neutrophils

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

N-Formyl-methionyl-leucyl-phenylalanine (FMLP) stimulated a timeand concentration-dependent release of granule associatedβ-glucuronidase and lysozyme but not cytoplasmic lactate dehydrogenase from human neutrophils. Maximum discharge of lysosomal enzymes occurred two minutes after cell contact with FMLP. The percent of total enzyme activity released is insignificant when cells are not preincubated with cytochalasin B prior to being exposed to FMLP (10−10-10−7 M); although 11.2 ± 1.3 and 12.4 ±1.1% of total activity forβ-glucuronidase and lysozyme, respectively, is secreted from neutrophils with 10−4 M FMLP in the absence of cytochalasin B. FMLP-stimulated release of lysosomal enzymes occurs but is significantly curtailed in the absence of extracellular calcium. Incubation of neutrophils with EGTA in calcium-free medium, however, had no effect on FMLP-elicited lysosomal enzyme extrusion. 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8), a purported antagonist of intracellular calcium, demonstrated a dose-dependent inhibition of FMLP-induced release ofβ-glucuronidase and lysozyme from cytochalasin B-treated neutrophils in the absence of extracellular calcium. This effect of TMB-8 could be reversed with the addition of calcium to the extracellular medium. These studies indicate that TMB-8 may be useful in elucidating the role of calcium in the mechanism of lysosomal enzyme release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cochrane, C. G. 1968. Immunologie tissue injury mediated by neutrophilic leukocytes.Adv. Immunol. 9:97.

    Google Scholar 

  2. Schiffmann, E., B. A. Corcoran, andS. M. Wahl. 1975. N-formylmethionyl peptides as chemoattractants for leukocytes.Proc. Nat. Acad. Sci. U.S.A. 72:1059.

    Google Scholar 

  3. Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. Corcohan, andE. L. Becker. 1976. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils.J. Exp. Med. 143:1154.

    Google Scholar 

  4. Smith, R. J. 1978. Nonsteroid anti-inflammatory agents: Regulators of the phagocytic secretion of lysosomal enzymes from guinea-pig neutrophils.J. Pharmacol. Exp. Ther. 207:618.

    Google Scholar 

  5. Worthington Enzyme Manual. 1972. Worthington Biochemical Corp. Freehold, New Jersey. 100–101.

  6. Sastry, B. V. R., andA. Lasslo. 1958. Aliphatic reserpine analogs.J. Org. Chem. 23:1577.

    Google Scholar 

  7. Malagodi, M. H., andC. Y. Chiou. 1974. Pharmacological evaluation of a new Ca++ antagonist, 8-(N, N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8): Studies in smooth muscles.Eur. J. Pharmacol. 27:25.

    Google Scholar 

  8. Day, A. R., R. J. Freer, H. J. Showell, andE. L. Becker. 1977. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.Biochem. Biophys. Res. Commun. 74:810.

    Google Scholar 

  9. Williams, L. T., R. Snyderman, M. C. Pike, andR. J. Lefkowitz. 1977. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.Proc. Natl. Acad. Sci. U.S.A. 74:1204.

    Google Scholar 

  10. Henson, P. M. 1971. Interaction of cells with immune complexes: Adherence, release of constituents, and tissue injury.J. Exp. Med. 134(3,Pt. 2): 114s.

    Google Scholar 

  11. Hawkins, D. 1972. Neutrophilic leukocytes in immunologic reactions: Evidence for the selective release of lysosomal constituents.J. Immunol. 108:310.

    Google Scholar 

  12. Becker, E. L., H. J. Showell, P. M. Henson, andL. S. Hsu. 1974. The ability of chemotactic factors to induce lysosomal enzyme release, I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness.J. Immunol. 112:2047.

    Google Scholar 

  13. Goldstein, I., S. Hoffstein, J. Gallin, andG. Weissmann. 1973. Mechanisms of lysosomal enzyme release from human leukocytes: Microtubule assembly and membrane fusion induced by a component of complement.Proc. Natl. Acad. Sci U.S.A. 70:2916.

    Google Scholar 

  14. Becker, E. L., andH. J. Showell. 1974. The ability of chemotactic factors to induce lysosomal enzyme release: II. The mechanism of release.J. Immunol. 112:2055.

    Google Scholar 

  15. Davis, A. T., R. Estensen, andP. G. Quie. 1971. Cytochalasin B: 3. Inhibition of human polymorphonuclear leukocyte phagocytosis.Proc. Soc. Exp. Biol. Med. 137:161.

    Google Scholar 

  16. Woodin, A. M., andA. A. Weineke. 1963. The accumulation of calcium by the polymorphonuclear leukocyte treated with staphylococcal leucocidin and its significance in the extrusion of protein.Biochem. J. 87:487.

    Google Scholar 

  17. Smith, R. J., andL. J. Ignarro. 1975. Bioregulation of lysosomal enzyme secretion from human neutrophils: Roles of guanosine 3':5'-monophosphate and calcium in stimulussecretion coupling.Proc. Natl. Acad. Sci. U.S.A. 72:108.

    Google Scholar 

  18. Smith, R. J. 1979. The guinea pig neutrophil calcium-dependent lysosomal enzyme secretory process: Inhibition by nonsteroid anti-inflammatory agents.Biochem. Pharmacol 28:2739.

    Google Scholar 

  19. Northover, B. J. 1977. Effect of indomethacin and related drugs on the calcium-dependent secretion of lysosomal and other enzymes by neutrophil polymorphonuclear leukocytes in vitro.Br. J. PharmacoL 59:253.

    Google Scholar 

  20. Henson, P. M. 1972. Pathologic mechanisms in neutrophil-mediated injury.Am. J. Pathol. 68:593.

    Google Scholar 

  21. Malagodi, M. H., andC. Y. Chiou. 1974. Pharmacological evaluation of a new Ca++ antagonist, 8-(N,N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8): Studies in skeletal muscles.Pharmacology 12:20.

    Google Scholar 

  22. Chiou, C. Y., andM. H. Malagodi. 1975. Studies on the mechanism of action of a new Ca++ antagonist, 8-(N,N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles.Br. J. Pharmacol. 53:279.

    Google Scholar 

  23. Charo, I. F., R. D. Feinman, andT. C. Detwiler. 1976. Inhibition of platelet secretion by an antagonist of intracellular calcium.Biochem. Biophys. Res. Commun. 72:1462.

    Google Scholar 

  24. Gorman, R. R., W. Wierenga, andO. V. Miller. 1979. Independence of the Cyclic AMP- lowering activity of Thromboxane A2 from the platelet release reaction.Biochim. Biophys. Acta 572:95.

    Google Scholar 

  25. Naccache, P. H., H. J. Showell, E. L. Becker, andR. I. Sha'afi. 1977. Changes in ionic movements across rabbit polymorphonuclear leukocyte membranes during lysosomal enzyme release: Possible ionic basis for lysosomal enzyme release.J. Cell Biol. 75:635.

    Google Scholar 

  26. Naccache. P. H., M. Volpi, H. J. Showell, E. L. Becker, andR. I. Sha'afi. 1979. Chemotactic factor induced release of membrane calcium in rabbit neutrophils.Science 203:461.

    Google Scholar 

  27. O'flaherty, J. T., H. J. Showell, E. L. Becker, andP. A. Ward. 1979. Neutrophil aggregation: Effect of the time and sequence of addition of calcium, magnesium and chemotactic factor.J. Reticuloendothel. Soc. 25:29.

    Google Scholar 

  28. Naccache, P. H., H. J. Showell, E. L. Becker, andR. I. Sha'afi. 1977. Transport of sodium, potassium and calcium across rabbit polymorphonuclear leukocyte membranes: Effect of chemotactic factor.J. Cell Biol. 73:428.

    Google Scholar 

  29. Becker, E. L., M. Sigman, andJ. M. Oliver. 1979. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.Am. J. Pathol. 95:81.

    Google Scholar 

  30. Avila, J. L., andJ. Convit. 1973. Studies of human polymorphonuclear leukocyte enzymes: I. Assay of acid hydrolases and other enzymes.Biochem. Biophys. Acts 293:397.

    Google Scholar 

  31. Bainton, D. F., J. L. Ullyot, andM. G. Farquhar. 1971. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.J. Exp. Med. 134:907.

    Google Scholar 

  32. Bentwood, B. J. 1979. Sequential degranulation of human neutrophils.Fed. Proc. 38(Part 2):1362.

    Google Scholar 

  33. Estensen, R. D., J. G. White, andB. Holmes. 1974. Specific degranulation of human polymorphonuclear leukocytes.Nature (London) 248:347.

    Google Scholar 

  34. Bainton, D. F. 1973. Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms.J. Cell Biol. 58:249.

    Google Scholar 

  35. Nachman, R., J. G. Hirsch, andM. Baggiolini. 1972. Studies on isolated membranes of azurophil and specific granules from rabbit polymorphonuclear leukocytes.J. Cell Biol. 54:133.

    Google Scholar 

  36. Avila, J. L., andJ. Convit. 1973. Studies on human polymorphonuclear leukocyte enzymes: II. Comparative study of the physical properties of primary and specific granules.Biochim. Biophys. Acta 293:409.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, R.J., Wierenga, W. & Iden, S.S. Characteristics ofN-formyl-methionyl-leucyl-phenylalanine as an inducer of lysosomal enzyme release from human neutrophils. Inflammation 4, 73–88 (1980). https://doi.org/10.1007/BF00914105

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00914105

Keywords

Navigation